A detailed history of Operose Advisors LLC transactions in Medtronic PLC stock. As of the latest transaction made, Operose Advisors LLC holds 590 shares of MDT stock, worth $50,551. This represents 0.02% of its overall portfolio holdings.

Number of Shares
590
Previous 590 -0.0%
Holding current value
$50,551
Previous $46,000 15.22%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$82.84 - $88.09 $28,579 - $30,391
-345 Reduced 36.9%
590 $51,000
Q4 2023

Feb 12, 2024

SELL
$69.43 - $83.43 $30,549 - $36,709
-440 Reduced 32.0%
935 $77,000
Q3 2023

Nov 13, 2023

BUY
$78.22 - $90.4 $107,552 - $124,300
1,375 New
1,375 $107,000
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $40,375 - $47,655
-500 Reduced 85.47%
85 $7,000
Q1 2022

May 12, 2022

BUY
$100.58 - $112.38 $58,839 - $65,742
585 New
585 $65,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $114B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.